Product Code: ETC10735557 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Osteoporosis Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Osteoporosis Market Revenues & Volume, 2021 & 2031F |
3.3 China Osteoporosis Market - Industry Life Cycle |
3.4 China Osteoporosis Market - Porter's Five Forces |
3.5 China Osteoporosis Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 China Osteoporosis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 China Osteoporosis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 China Osteoporosis Market Revenues & Volume Share, By Diagnosis Method, 2021 & 2031F |
4 China Osteoporosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in China leading to a higher prevalence of osteoporosis |
4.2.2 Growing awareness about osteoporosis and its consequences among the Chinese population |
4.2.3 Technological advancements in diagnosis and treatment options for osteoporosis |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services, especially in rural areas, impacting diagnosis and treatment of osteoporosis |
4.3.2 High cost of osteoporosis medications and treatment, making it less accessible to a significant portion of the population |
4.3.3 Cultural beliefs and practices that may hinder individuals from seeking timely medical intervention for osteoporosis |
5 China Osteoporosis Market Trends |
6 China Osteoporosis Market, By Types |
6.1 China Osteoporosis Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 China Osteoporosis Market Revenues & Volume, By Disease Type, 2021 - 2031F |
6.1.3 China Osteoporosis Market Revenues & Volume, By Primary Osteoporosis, 2021 - 2031F |
6.1.4 China Osteoporosis Market Revenues & Volume, By Secondary Osteoporosis, 2021 - 2031F |
6.1.5 China Osteoporosis Market Revenues & Volume, By Postmenopausal Osteoporosis, 2021 - 2031F |
6.1.6 China Osteoporosis Market Revenues & Volume, By Senile Osteoporosis, 2021 - 2031F |
6.2 China Osteoporosis Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 China Osteoporosis Market Revenues & Volume, By Medication, 2021 - 2031F |
6.2.3 China Osteoporosis Market Revenues & Volume, By Lifestyle Modification, 2021 - 2031F |
6.2.4 China Osteoporosis Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.2.5 China Osteoporosis Market Revenues & Volume, By Surgery, 2021 - 2031F |
6.3 China Osteoporosis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Osteoporosis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 China Osteoporosis Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.4 China Osteoporosis Market Revenues & Volume, By Homecare Settings, 2021 - 2031F |
6.4 China Osteoporosis Market, By Diagnosis Method |
6.4.1 Overview and Analysis |
6.4.2 China Osteoporosis Market Revenues & Volume, By Bone Density Test, 2021 - 2031F |
6.4.3 China Osteoporosis Market Revenues & Volume, By X-ray, 2021 - 2031F |
6.4.4 China Osteoporosis Market Revenues & Volume, By MRI Scan, 2021 - 2031F |
7 China Osteoporosis Market Import-Export Trade Statistics |
7.1 China Osteoporosis Market Export to Major Countries |
7.2 China Osteoporosis Market Imports from Major Countries |
8 China Osteoporosis Market Key Performance Indicators |
8.1 Average bone mineral density (BMD) levels among the Chinese population |
8.2 Percentage of osteoporosis patients receiving timely diagnosis and treatment |
8.3 Number of osteoporosis awareness campaigns and their reach in the Chinese population |
9 China Osteoporosis Market - Opportunity Assessment |
9.1 China Osteoporosis Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 China Osteoporosis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 China Osteoporosis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 China Osteoporosis Market Opportunity Assessment, By Diagnosis Method, 2021 & 2031F |
10 China Osteoporosis Market - Competitive Landscape |
10.1 China Osteoporosis Market Revenue Share, By Companies, 2024 |
10.2 China Osteoporosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |